AminoAnalytica

Name: AminoAnalytica
Brand: AminoAnalytica

AI Native

Autonomous protein design.

Est 2024|Raised $500K

LinkedIn 1K|Website|FTEs 4|HQ San Francisco, California, US

01Competitive Landscape

Narrative analysis

Where AminoAnalytica may be competitive - Teams whose primary bottleneck is installing tools and orchestrating GPU compute may find value in a packaged platform that reduces DevOps work. - If the platform integrates a broad set of commonly used tools and supports web, CLI, and assistant-driven workflows, it can reduce context switching for some users. Where competitors may be preferred - Benchling is positioned as a system of record for laboratory and R&D data and may provide stronger governance and broader adoption in biotech organizations. - Arzeda may be preferable when buyers seek validated protein outcomes and wet-lab follow-up rather than a self-serve computational platform. - An internal DIY stack offers maximum control, explicit version pinning, and data residency at the cost of higher DevOps burden. Adoption signals - Participation in a notable accelerator program in 2024 indicates early-stage investor backing but does not substitute for adoption in enterprise procurement. - Limited presence on review platforms and forums suggests the product is early in mainstream enterprise adoption.

	AminoAnalytica (Amina)	Benchling	Arzeda
Starting Price	Initial free compute credit; vendor-cited usage-based GPU compute pricing (published usage-based pricing available from the vendor)	Public pricing is largely enterprise/tailored; some third-party references to entry tiers exist but official pricing should be confirmed	Typically engagement-based; not primarily self-serve SaaS
Typical Fit	Teams seeking a packaged environment for multiple protein design tools with orchestration and on-demand compute	Organizations seeking an end-to-end R&D data platform (ELN/registry/workflows) with governance features	Companies seeking an outcomes-oriented protein design and validation partner
Key Strength	Reduced setup effort and integrated orchestration across tools; pay-as-you-go compute model	Mature enterprise footprint and R&D governance features	Wet-lab validation and commercialization capabilities
Key Weakness	Limited public enterprise security evidence and limited third-party reviews; early-stage vendor	Not specifically focused on compute orchestration for protein design; potential complexity at scale	Less focused on self-serve computational tool access; engagement-based model

01Competitive Landscape

Narrative analysis

Where AminoAnalytica may be competitive

Teams whose primary bottleneck is installing tools and orchestrating GPU compute may find value in a packaged platform that reduces DevOps work.
If the platform integrates a broad set of commonly used tools and supports web, CLI, and assistant-driven workflows, it can reduce context switching for some users.

Where competitors may be preferred

Benchling is positioned as a system of record for laboratory and R&D data and may provide stronger governance and broader adoption in biotech organizations.
Arzeda may be preferable when buyers seek validated protein outcomes and wet-lab follow-up rather than a self-serve computational platform.
An internal DIY stack offers maximum control, explicit version pinning, and data residency at the cost of higher DevOps burden.

Adoption signals

Participation in a notable accelerator program in 2024 indicates early-stage investor backing but does not substitute for adoption in enterprise procurement.
Limited presence on review platforms and forums suggests the product is early in mainstream enterprise adoption.

	AminoAnalytica (Amina)	Benchling	Arzeda
Starting Price	Initial free compute credit; vendor-cited usage-based GPU compute pricing (published usage-based pricing available from the vendor)	Public pricing is largely enterprise/tailored; some third-party references to entry tiers exist but official pricing should be confirmed	Typically engagement-based; not primarily self-serve SaaS
Typical Fit	Teams seeking a packaged environment for multiple protein design tools with orchestration and on-demand compute	Organizations seeking an end-to-end R&D data platform (ELN/registry/workflows) with governance features	Companies seeking an outcomes-oriented protein design and validation partner
Key Strength	Reduced setup effort and integrated orchestration across tools; pay-as-you-go compute model	Mature enterprise footprint and R&D governance features	Wet-lab validation and commercialization capabilities
Key Weakness	Limited public enterprise security evidence and limited third-party reviews; early-stage vendor	Not specifically focused on compute orchestration for protein design; potential complexity at scale	Less focused on self-serve computational tool access; engagement-based model

AminoAnalytica

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map